Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Articles
Editors' (re)View: FDA shares early AD industry guidance; WuXi-BIO breakup
March 15, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 11
Anticipating AI regulations in pharma manufacturing
March 11, 2024
In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation
Leveraging lean innovation principles
March 11, 2024
How pharma can apply tactics from other industries to tackle recent policy cost initiatives
Charting a sustainable path for generics
March 8, 2024
Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
Editors' (re)View: Perrigo launches OTC birth control; Lilly takes aim at celebs
March 8, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 4
Breaking down pharma compliance barriers
March 7, 2024
How pharma companies are solving regulatory challenges with AI-based technology
Navigating the smaller batch market
March 5, 2024
Pharma innovators are using technology to meet the unique demands of today’s small scale era
FDA decisions to watch in 2024
March 5, 2024
This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more
5 Pharma changemakers
March 1, 2024
The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry
Editors' (re)View: Probing pharma-sponsored testing; FDA approves Alvotech-Teva Humira biosim
March 1, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 24
Pharma CDMOs with sky-high ambitions
Feb. 29, 2024
A snapshot of the bold CDMOs working to build pharma’s modern treatments
Pharma Manufacturing job function
Feb. 28, 2024
The role of workwear in mitigating pharma workplace hazards
Feb. 28, 2024
Ergonomic clothing explicitly designed for the industry helps avoid common safety incidents, as well as aid in compliance
Matica Biotechnology: Filling the void
Feb. 27, 2024
With a dedication to advanced technologies, the Texas-based CDMO is helping quickly bring cell and gene therapies from idea to patient
INCOG Biopharma: Pedaling towards excellence
Feb. 27, 2024
The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology
Cellares: A disruptive impact on cell therapy
Feb. 27, 2024
The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...
ten23 health: Sustainable success
Feb. 27, 2024
With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines
Raising a modern pharma CDMO
Feb. 27, 2024
Four young companies built with intention tackle the future of medicine
What pharma needs to know about transfer pricing
Feb. 26, 2024
Transfer pricing analysis helps companies to manage tax risks as well as identify business opportunities
Editors' (re)View: Landmark approval for solid tumors; Relief for food allergy sufferers
Feb. 23, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 19
Reframing OEE in pharma
Feb. 21, 2024
Modern technologies can transform overall equipment effectiveness from an operations metric into a valuable source of data
The shape of pharma to come
Feb. 21, 2024
Staying flexible in response to shifting supply chains in 2024
Editors' (re)View: Humira's patent blip; Hope for pancreatic cancer
Feb. 16, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of February 12
Protecting pharma's most valuable asset: intellectual property
Feb. 15, 2024
By taking the necessary precautions, pharma manufacturers can minimize the damage to their company when things go wrong
How real-time metrics can drive quality excellence beyond compliance
Feb. 12, 2024
Establishing foundational quality data and real-time reporting is a priority to reach proactive quality management
Editors' (re)View: Lilly weighs in on Novo deal; J&J drug brings immune disease hope
Feb. 9, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of February 5
5 expert insights on generics and biosimilars
Feb. 8, 2024
Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
Editors' (re)View: CMS commits to improving CGT access; The Aduhelm exit
Feb. 2, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of January 28
2024 pharma predictions: Regulations, sustainability and culture
Jan. 31, 2024
In part 2 of our series, leaders weigh in on what the pharma industry can expect in the coming year
2024 pharma predictions: Therapeutic advances, manufacturing tech
Jan. 31, 2024
In our two-part series, leaders weigh in on what the pharma industry can expect in the coming year
Load More Content